Monthly Archives: June 2021

The FDA grants an accelerated approval for Biogen’s aducanumab for the treatment of Alzheimer’s disease

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com        SPECIAL REPORT #21.17     The FDA grants an accelerated approval for Biogen’s aducanumab for the treatment of Alzheimer’s disease     The U.S. FDA approves today Biogen’s aducanumab for the treatment of Alzheimer’s disease in stating “the drug consistently and very […]

read more